Pilot study of baricitinib for active Sjogren's syndrome

Wei Bai; Huilan Liu; Lei Dou; YunJiao Yang; XiaoMei Leng; Mengtao Li; Wen Zhang; Yan Zhao; Xiaofeng Zeng

doi:10.1136/annrheumdis-2021-222053

Pilot study of baricitinib for active Sjogren's syndrome

Ann Rheum Dis. 2022 Jul;81(7):1050-1052. doi: 10.1136/annrheumdis-2021-222053. Epub 2022 Mar 25.

Authors

Wei Bai^{1

2}, Huilan Liu^{1

2}, Lei Dou³, YunJiao Yang^{1

2}, XiaoMei Leng^{4

2}, Mengtao Li^{1

2}, Wen Zhang^{1

2}, Yan Zhao^{4

2}, Xiaofeng Zeng^{1

2}

Affiliations

¹ Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Dongcheng-qu, Beijing, China.
² Department of Rheumatology and Clinical Immunology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.
³ Department of Rheumatology and Immunology, The Second People's Hospital of Wuhu, Wuhu, Anhui, China.
⁴ Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Dongcheng-qu, Beijing, China lpumch@126.com zhaoyan_pumch2002@aliyun.com.

PMID: 35338034
DOI: 10.1136/annrheumdis-2021-222053

No abstract available

Keywords: autoimmune diseases; sjogren's syndrome; therapeutics.

Publication types

Research Support, Non-U.S. Gov't
Letter

MeSH terms

Azetidines* / therapeutic use
Humans
Pilot Projects
Purines / therapeutic use
Pyrazoles
Sjogren's Syndrome* / drug therapy
Sulfonamides

Substances

Azetidines
Purines
Pyrazoles
Sulfonamides
baricitinib